Article Text
Summary
Non-vitamin K oral anticoagulants (NOACs) are being increasingly prescribed. These drugs act rapidly, have predictable dose-related anticoagulation effect and require no routine laboratory monitoring, making them attractive for both patients and healthcare providers. All NOACs are at least partially excreted thought the kidneys. Renal injury related to NOAC use is being increasingly reported. NOAC-related acute interstitial nephritis (AIN) has only been reported once and that was in context of dabigatran use. We describe the first case of apixaban-related AIN. This case adds an important differential diagnoses that should be considered for any patient presenting with renal injury while being treated with NOACs.
- drugs and medicines
- renal system
- acute renal failure
Statistics from Altmetric.com
Footnotes
Contributors BA contributed to conception and design, analysis of data as well as drafting the work and revising it critically for important intellectual content. RM contributed to the conception and design of the work and to the analysis and interpretation of data. AG contributed to the conception and design of the work and to the analysis and interpretation of data. JR contributed to the concept and design, critical writing and revision of the intellectual content, final approval for the version to be published.
Competing interests None declared.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.